PCRNX
Price
$14.15
Change
+$0.09 (+0.64%)
Updated
Oct 6 closing price
Net Assets
3.42B
PCSRX
Price
$12.62
Change
+$0.08 (+0.64%)
Updated
Oct 6 closing price
Net Assets
3.42B
Interact to see
Advertisement

PCRNX vs PCSRX

Header iconPCRNX vs PCSRX Comparison
Open Charts PCRNX vs PCSRXBanner chart's image
PIMCO Commodity Real Ret Strat I-3
Price$14.15
Change+$0.09 (+0.64%)
VolumeN/A
Net Assets3.42B
PIMCO Commodity Real Ret Strat R
Price$12.62
Change+$0.08 (+0.64%)
VolumeN/A
Net Assets3.42B
PCRNX vs PCSRX Comparison Chart in %
View a ticker or compare two or three
VS
PCRNX vs. PCSRX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCRNX is a Hold and PCSRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PCRNX (3.42B) and PCSRX (3.42B) have equal amount of cash in the bank . PCSRX (6.50) and PCRNX (6.21) have matching dividends . PCRNX was incepted earlier than PCSRX: PCRNX (7 years) vs PCSRX (16 years). PCSRX (1.68) is less costly to investors than PCRNX (1.18). PCRNX (268.00) and PCSRX (268.00) have comparable annual turnover. PCSRX has a lower initial minimum investment than PCRNX: PCSRX (0) vs PCRNX (1000000). PCRNX annual gain was more profitable for investors over the last year : 10.41 vs. PCSRX (9.83). PCRNX return over 5 years is better than : 77.65 vs. PCSRX (72.83).
PCRNXPCSRXPCRNX / PCSRX
Total Expense Ratio1.051.6066%
Annual Report Gross Expense Ratio1.181.6870%
Fund Existence7 years16 years-
Gain YTD14.25213.873103%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.42B3.42B100%
Annual Yield % from dividends6.216.5096%
Returns for 1 year10.419.83106%
Returns for 3 years7.816.04129%
Returns for 5 years77.6572.83107%
Returns for 10 yearsN/A47.52-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECEMX17.07N/A
N/A
Parametric Emerging Markets C
FDCAX48.37N/A
N/A
Fidelity Capital Appreciation
AVPEX13.70N/A
N/A
ALPS Global Opportunity Portfolio Cl III
AGYGX13.15N/A
N/A
American Century Focused Global Gr Y
MXHAX13.21N/A
N/A
Empower Large Cap Value Inv II